Insulin Therapy Center

In this week's Homerun Slides, the study and results of the addition of insulin detemir to Liraglutide treatment of type 2 diabetes.

In a follow-up visit for an insulin-requiring patient with type 2 DM, it was obvious that the management of his DM had deteriorated. According to his girlfriend, this patient ate only 1-2 meals a day, but they tended to be high-carbohydrate meals. We reviewed the patient's insulin regimem in detail and ascertained that he was using the sliding scale correctly.

Findings suggest that helping patients respond effectively to eating disorder symptoms might decrease insulin restriction.

New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.

In this week's Homerun Slides, the effectiveness of Lixisenatide when added to basal insulin, and strategies for avoiding or minimizing the GI effects of GLP-1.

Patient history of CVD, higher A1C factored into risk.

Findings suggest treatment may reduce urine albumin creatinine ratio in T1DM.

Medicaid reimbursement for insulin skyrocketed within the last decade.

In this week's Homerun Slides, the results of a multinational, placebo-controlled, randomized, double-blind, parallel-group, 24-week study involving patients who were receiving insulin (not routine pre-meal short- or rapid-acting insulin, except as pre-mixed insulin) administered alone or in combination with metformin (³1500 mg per day) and who had inadequate glycemic control (A1C ³7.5% and ≤11%).

Diabetes in Control publisher Steve Freed meets with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. Dr. Hirsch talks about the work toward improving patient experience when taking injections and the results of a study on the nano needle use in obese patients.